Are Gadolinium-Enhanced MR Sequences Needed in Simultaneous


Journal

AJNR. American journal of neuroradiology
ISSN: 1936-959X
Titre abrégé: AJNR Am J Neuroradiol
Pays: United States
ID NLM: 8003708

Informations de publication

Date de publication:
10 2020
Historique:
received: 10 07 2019
accepted: 21 06 2020
pubmed: 26 9 2020
medline: 9 2 2021
entrez: 25 9 2020
Statut: ppublish

Résumé

PET/MRI with Consecutive patients who underwent simultaneous head and neck Thirty patients were included. There was excellent agreement between the contrast-free and postgadolinium reading sessions in delineating precise tumor extension in the 45 anatomic regions studied (Cohen κ = 0.96, 95% CI = [0.94-0.97], Gadolinium chelate contrast administration showed no added value for accurate characterization of head and neck primary tumor extension and could possibly be avoided in the PET/MR imaging head and neck workflow.

Sections du résumé

BACKGROUND AND PURPOSE
PET/MRI with
MATERIALS AND METHODS
Consecutive patients who underwent simultaneous head and neck
RESULTS
Thirty patients were included. There was excellent agreement between the contrast-free and postgadolinium reading sessions in delineating precise tumor extension in the 45 anatomic regions studied (Cohen κ = 0.96, 95% CI = [0.94-0.97],
CONCLUSIONS
Gadolinium chelate contrast administration showed no added value for accurate characterization of head and neck primary tumor extension and could possibly be avoided in the PET/MR imaging head and neck workflow.

Identifiants

pubmed: 32972956
pii: ajnr.A6764
doi: 10.3174/ajnr.A6764
pmc: PMC7661078
doi:

Substances chimiques

Contrast Media 0
Radiopharmaceuticals 0
Fluorodeoxyglucose F18 0Z5B2CJX4D
Gadolinium AU0V1LM3JT

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1888-1896

Informations de copyright

© 2020 by American Journal of Neuroradiology.

Références

Eur J Nucl Med Mol Imaging. 2014 Jun;41(6):1066-75
pubmed: 24577950
Nucl Med Commun. 2015 Apr;36(4):312-8
pubmed: 25514551
Nucl Med Mol Imaging. 2014 Jun;48(2):98-105
pubmed: 24900149
Eur Radiol. 2011 Jul;21(7):1439-46
pubmed: 21308378
J Nucl Med. 2016 Jan;57(1):70-7
pubmed: 26471690
Annu Rev Med. 2016;67:273-91
pubmed: 26768242
Radiology. 2015 Jun;275(3):772-82
pubmed: 25742194
Eur J Nucl Med Mol Imaging. 2014 Mar;41(3):462-75
pubmed: 24108458
AJNR Am J Neuroradiol. 2006 Nov-Dec;27(10):2024-36
pubmed: 17110661
EJNMMI Phys. 2014 Dec;1(1):103
pubmed: 26501461
Eur J Nucl Med Mol Imaging. 2014 Apr;41(4):639-48
pubmed: 24292211
Eur J Nucl Med Mol Imaging. 2011 Nov;38(11):2083-95
pubmed: 21853309
Ann Otol Rhinol Laryngol. 2008 Nov;117(11):854-63
pubmed: 19102133
Am J Epidemiol. 2006 Apr 1;163(7):670-5
pubmed: 16410346
Rofo. 2017 May;189(5):413-422
pubmed: 28449168
Eur Radiol. 2018 Feb;28(2):651-663
pubmed: 28812148
Diagn Interv Radiol. 2017 Mar-Apr;23(2):127-132
pubmed: 28089955
J Healthc Eng. ;2017:
pubmed: 29076331
Clin Transl Oncol. 2006 Oct;8(10):711-6
pubmed: 17074669
Eur Radiol. 2000;10(10):1669-74
pubmed: 11044946
Jpn J Clin Oncol. 2018 Jul 01;48(7):633-639
pubmed: 29718274
J Nucl Med. 2014 May 1;55(Supplement 2):19S-24S
pubmed: 24790220
AJR Am J Roentgenol. 2009 Dec;193(6):1607-14
pubmed: 19933655
Eur J Nucl Med Mol Imaging. 2011 Jun;38(6):1009-19
pubmed: 21465255
Nucl Med Commun. 2015 Dec;36(12):1165-73
pubmed: 26397999
Eur J Nucl Med Mol Imaging. 2013 Jan;40(1):6-11
pubmed: 23053322
Oncology. 2016;91(1):13-23
pubmed: 27245686
J Nucl Med. 2007 Mar;48(3):373-8
pubmed: 17332614
Radiology. 1991 Apr;179(1):191-8
pubmed: 2006277
Pediatr Nephrol. 2014 Oct;29(10):1927-37
pubmed: 24146299
AJR Am J Roentgenol. 1994 Jul;163(1):173-8
pubmed: 8010208
N Engl J Med. 1995 Dec 28;333(26):1757-63
pubmed: 7491141
Eur J Nucl Med Mol Imaging. 2014 Dec;41(12):2212-21
pubmed: 25091219
PLoS One. 2016 Jun 21;11(6):e0157880
pubmed: 27327617
J Nucl Med. 2014 Apr;55(4):551-8
pubmed: 24491410
Eur J Nucl Med Mol Imaging. 2016 Jan;43(1):92-102
pubmed: 26243264
Eur Radiol. 1998;8(9):1552-7
pubmed: 9866760
J Magn Reson Imaging. 2009 Dec;30(6):1236-9
pubmed: 19938035
Head Neck. 2015 Jul;37(7):1038-45
pubmed: 24710845
Insights Imaging. 2014 Oct;5(5):585-602
pubmed: 25154759

Auteurs

N Pyatigorskaya (N)

From Assistance Publique Hôpitaux de Paris Neuroradiology Department (N.P., E.C., D.D., M.A.-S.) nadya.pyatigorskaya@gmail.com.
Sorbonne University (N.P., D.D.), Pierre and Marie Faculty of Medicine, Paris, France.

R De Laroche (R)

Nuclear Medicine Department (R.D.L.), Morvan Hospital, Brest, France.

G Bera (G)

Nuclear Medicine Department (G.B., S.B., A.K.), Pitié-Salpêtrière-Charles Foix Hospital, Paris, France.

A Giron (A)

Sorbonne University (A.G., A.K.), Laboratoire d'Imagerie Biomédicale, Paris, France.

C Bertolus (C)

Sorbonne University, Maxillo-Facial Surgery Department (C.B.).
CIMI Sorbonne University UPMC (C.B.), Paris, France.

G Herve (G)

Pathology Department (G.H.), Pitié Salpêtrière-Charles Foix Hospital, Assistance Publique Hôpitaux de Paris, Paris, France.

E Chambenois (E)

From Assistance Publique Hôpitaux de Paris Neuroradiology Department (N.P., E.C., D.D., M.A.-S.).

S Bergeret (S)

Nuclear Medicine Department (G.B., S.B., A.K.), Pitié-Salpêtrière-Charles Foix Hospital, Paris, France.

D Dormont (D)

From Assistance Publique Hôpitaux de Paris Neuroradiology Department (N.P., E.C., D.D., M.A.-S.).
Sorbonne University (N.P., D.D.), Pierre and Marie Faculty of Medicine, Paris, France.

M Amor-Sahli (M)

From Assistance Publique Hôpitaux de Paris Neuroradiology Department (N.P., E.C., D.D., M.A.-S.).

A Kas (A)

Nuclear Medicine Department (G.B., S.B., A.K.), Pitié-Salpêtrière-Charles Foix Hospital, Paris, France.
Sorbonne University (A.G., A.K.), Laboratoire d'Imagerie Biomédicale, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH